Mar 15, 2022 / Chapters Appendix A: Commissioners’ voting on recommendations (March 2022 Report) Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues
Mar 04, 2022 / Comment Letters MedPAC comment on CMS’s notice of proposed rulemaking on contract year 2023 policy and technical changes to Medicare Advantage and Part D Research Areas: Drugs, Devices, and Tests, Private Plans
Mar 03, 2022 / Presentations Medicare payment policies to support safety-net providers Research Areas: Hospitals
Feb 02, 2022 / Congressional Testimony Testimony: The Hospital Insurance Trust Fund and the Future of Medicare Financing (Senate Finance) Research Areas: Drugs, Devices, and Tests, Medicare Spending and Financing, Private Plans, Quality
Jan 14, 2022 / Presentations The Medicare prescription drug program (Part D): Status report Research Areas: Drugs, Devices, and Tests, Private Plans
Jan 13, 2022 / Transcripts January 2022 meeting transcript Research Areas: Ambulatory Care Settings, Beneficiaries and Coverage, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality
Nov 09, 2021 / Presentations Part D for residents in long-term care facilities Research Areas: Drugs, Devices, and Tests, Hospitals, Post-Acute Care
Oct 07, 2021 / Presentations Addressing high prices of pharmaceutical products (and other technologies) covered under Medicare Research Areas: Drugs, Devices, and Tests
Oct 07, 2021 / Presentations Data on Medicare’s net prices for prescription drugs and other drug pricing metrics Research Areas: Drugs, Devices, and Tests
Sep 02, 2021 / Presentations Potential reforms to Part D’s low-income premium subsidy Research Areas: Drugs, Devices, and Tests, Private Plans